Abstract
N(1)-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives were design, synthesized and tested for their in vitro antimycobacterial activity. The new compounds showed a moderate antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H37Ra and a significant antimycobacterial activity against several mycobacteria other than tuberculosis strains.
Keywords:
Antimycobacterial activity; Mycobacteria other than tuberculosis (MOTT); Pyridine-2-carboxamidrazone derivatives.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology*
-
Antifungal Agents / chemical synthesis
-
Antifungal Agents / chemistry
-
Antifungal Agents / pharmacology*
-
Bacteria / drug effects*
-
Dose-Response Relationship, Drug
-
Fungi / drug effects*
-
Imidazoles / chemical synthesis
-
Imidazoles / chemistry
-
Imidazoles / pharmacology*
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Pyridines / chemical synthesis
-
Pyridines / chemistry
-
Pyridines / pharmacology*
-
Structure-Activity Relationship
Substances
-
Anti-Bacterial Agents
-
Antifungal Agents
-
Imidazoles
-
Pyridines